Clinical Case Reports (Apr 2021)

Rectal ulcer in a hemodialysis patient receiving Kayexalate®

  • Julia Collot,
  • Tayeb Salaouatchi,
  • Fabienne Rickaert,
  • Albino Floriani,
  • Benoit Buysschaert,
  • Maria Mesquita,
  • Eric Godon

DOI
https://doi.org/10.1002/ccr3.4043
Journal volume & issue
Vol. 9, no. 4
pp. 2385 – 2389

Abstract

Read online

Abstract Kayexalate can cause severe unrecognized GI lesions. Diagnosis of kayexalate crystals in GI biopsy samples is important. Pathologists and clinicians should work hand in hand. New drugs should be available to all patients to treat hyperkalemia.

Keywords